Effects of the BPAL Regimen On Hematological Parameters In Patients With Multidrug-Resistant Tuberculosis
Diponegoro International Medical Journal · 31.07.2026 · 7 (1) · 6-10
DOI: 10.14710/dimj.v7i1.30994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diponegoro International Medical Journal, online erschienen am 31.07.2026. Verfasst von Dwi Retnoningrum und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
BPaL is a new oral drug combination consisting of Bedaquiline (B), Pretomanid (Pa) and Linezolid (L) for multi-drug resistance tuberculosis. In Indonesia BPaL has been officially launched by the government as a therapeutic regimen for multidrug resistant tuberculosis patients since August 2023. One of the drugs in this regimen has the side effect of anemia. Until now, there are still no references explaining the effect of BPaL on the hematological profile.
Objective
To determine the differences in the hematological profile of multidrug resistance tuberculosis patients before receiving the multi drug resistance regimen BPaL anti-tuberculosis drug regimen and while receiving the multi drug resistance regimen BPaL anti-tuberculosis drug regimen.
Methods
This research was a retrospective observational analytical study with a retrospective cohort design involving patients with multidrug-resistant tuberculosis in Kariadi Hospital based on medical records. The difference test used the paired T-test and the Wilcoxon test.
Results
40 subjects were recruited, there were significant differences in hemoglobin level (p=0.003), hematocrit (p=0.002), red blood cells count (p=
Zitieren
APA
Retnoningrum, D., Assan, S. N., Cita, V. S., & Jaludamascena, A. (2026). Effects of the BPAL Regimen On Hematological Parameters In Patients With Multidrug-Resistant Tuberculosis. Diponegoro International Medical Journal, 7(1), 6-10. https://doi.org/10.14710/dimj.v7i1.30994
Vancouver
Retnoningrum D, Assan SN, Cita VS, Jaludamascena A. Effects of the BPAL Regimen On Hematological Parameters In Patients With Multidrug-Resistant Tuberculosis. Diponegoro International Medical Journal. 2026;7(1):6-10. doi:10.14710/dimj.v7i1.30994
BibTeX
@article{Retnoningrum2026,
author = {Retnoningrum, Dwi and Assan, Sustika Novianita and Cita, Villa Sekar and Jaludamascena, Ardhea},
title = {Effects of the BPAL Regimen On Hematological Parameters In Patients With Multidrug-Resistant Tuberculosis},
journal = {Diponegoro International Medical Journal},
year = {2026},
volume = {7},
number = {1},
pages = {6--10},
doi = {10.14710/dimj.v7i1.30994}
}
EUVIMED